EDGAR Filing Documents for 0001193125-17-344284

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-17-344284

Filing Date

2017-11-15

Accepted

2017-11-15 17:24:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d483476d424b5.htm	424B5	585604
2	GRAPHIC	g483476g15a09.jpg	GRAPHIC	23181
3	GRAPHIC	g483476g17z20.jpg	GRAPHIC	96771
4	GRAPHIC	g483476g18l48.jpg	GRAPHIC	122127
5	GRAPHIC	g483476g33q34.jpg	GRAPHIC	31748
6	GRAPHIC	g483476g47c73.jpg	GRAPHIC	44666
7	GRAPHIC	g483476g64p52.jpg	GRAPHIC	72072
8	GRAPHIC	g483476g69r78.jpg	GRAPHIC	46293
	Complete submission text file	0001193125-17-344284.txt		1188669

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR

Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207245 | Film No.: 171206046
SIC: 2834 Pharmaceutical Preparations